Back to Florida

HB0293 • 2026

Continuous Glucose Monitors

Continuous Glucose Monitors

Healthcare
Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Franklin
Last action
2026-03-13
Official status
House - Died in Health Care Facilities & Systems Subcommittee
Effective date
upon becom

Plain English Breakdown

The official source material does not provide specific details on costs, payment sources, or consequences if federal approval is denied.

Continuous Glucose Monitors for Medicaid

This bill requires the Agency for Health Care Administration to seek federal approval within 30 days of passing the law, so that continuous glucose monitors and related supplies can be covered as durable medical equipment under the Medicaid program.

What This Bill Does

  • Requires the Agency for Health Care Administration (AHCA) to apply for federal permission within 30 days after the bill becomes a law, so that continuous glucose monitors and related supplies can be covered by Medicaid as durable medical equipment.
  • Licensed durable medical equipment providers will get paid for providing these monitors and related supplies if they follow certain rules.

Who It Names or Affects

  • Medicaid recipients who need continuous glucose monitors
  • Licensed durable medical equipment providers

Terms To Know

Continuous Glucose Monitors (CGMs)
Devices that measure blood sugar levels continuously and send data to a receiver or smartphone.
Medicaid
A government program that helps low-income people pay for medical care.

Limits and Unknowns

  • The bill does not specify what happens if federal approval is denied.
  • It's unclear how much the coverage will cost or who will pay for it.

Bill History

  1. 2026-03-13 House

    • Died in Health Care Facilities & Systems Subcommittee

  2. 2026-01-13 House

    • 1st Reading (Original Filed Version)

  3. 2025-11-12 House

    • Referred to Health Care Facilities & Systems Subcommittee • Referred to Health Care Budget Subcommittee • Referred to Health & Human Services Committee • Now in Health Care Facilities & Systems Subcommittee

  4. 2025-11-03 House

    • Filed

Official Summary Text

Continuous Glucose Monitors; Requires AHCA to, within specified timeframe, seek federal approval as needed to provide coverage of continuous glucose monitors & related supplies as durable medical equipment benefit under Medicaid program; provides for reimbursement of such equipment; provides construction; requires agency to implement these changes upon receiving any necessary federal approval.

Current Bill Text

Read the full stored bill text
HB 293 2026

CODING: Words stricken are deletions; words underlined are additions.
hb293-00
Page 1 of 2
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

A bill to be entitled 1
An act relating to continuous glucose monitors; 2
requiring the Agency for Health Care Administration 3
to, within a specified timeframe, seek federal 4
approval as needed to provide coverage of continuous 5
glucose monitors and related supplies as a durable 6
medical equipment benefit under the Medicaid program; 7
providing for the reimbursement of such equipment; 8
providing construction; requiring the agency to 9
implement these changes upon receiving any necessary 10
federal approval; providing an effective date. 11
12
Be It Enacted by the Legislature of the State of Florida: 13
14
Section 1. (1) Within 30 days after this act becomes a 15
law, the Agency for Health Care Administration shall seek 16
federal approval through a Medicaid waiver or state plan 17
amendment as needed to provide coverage of continuous glucose 18
monitors and related supplies as a durable medical equipment 19
benefit for Medicaid recipients. A licensed durable medical 20
equipment provider must be reimbursed for continuous glucose 21
monitors and related supplies, provided the claim is submitted 22
through an active Medicare Healthcare Common Procedure Coding 23
System. The agency may not require such provider to use a 24
National Drug Code number as part of such claim submission. 25

HB 293 2026

CODING: Words stricken are deletions; words underlined are additions.
hb293-00
Page 2 of 2
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

(2) This section does not preclude the agency from 26
providing additional coverage of continuous glucose monitors as 27
a Medicaid pharmacy benefit. 28
(3) The agency shall begin implementation of these changes 29
upon receiving any necessary federal approval. 30
Section 2. This act shall take effect upon becoming a law. 31